126 related articles for article (PubMed ID: 23536694)
1. Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint.
Porter MD; Nicki J; Pool CD; DeBot M; Illam RM; Brando C; Bozick B; De La Vega P; Angra D; Spaccapelo R; Crisanti A; Murphy JR; Bennett JW; Schwenk RJ; Ockenhouse CF; Dutta S
Clin Vaccine Immunol; 2013 Jun; 20(6):803-10. PubMed ID: 23536694
[TBL] [Abstract][Full Text] [Related]
2. Strategic Variants of CSP Delivered as SynDNA Vaccines Demonstrate Heterogeneity of Immunogenicity and Protection from
Reeder SM; Bah MA; Tursi NJ; Brooks RC; Patel A; Esquivel R; Eaton A; Jhun H; Chu J; Kim K; Xu Z; Zavala F; Weiner DB
Infect Immun; 2021 Sep; 89(10):e0072820. PubMed ID: 34152830
[TBL] [Abstract][Full Text] [Related]
3. Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice.
Vom Steeg LG; Flores-Garcia Y; Zavala F; Klein SL
Vaccine; 2019 Jul; 37(32):4468-4476. PubMed ID: 31262583
[TBL] [Abstract][Full Text] [Related]
4. Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mice.
Kastenmüller K; Espinosa DA; Trager L; Stoyanov C; Salazar AM; Pokalwar S; Singh S; Dutta S; Ockenhouse CF; Zavala F; Seder RA
Infect Immun; 2013 Mar; 81(3):789-800. PubMed ID: 23275094
[TBL] [Abstract][Full Text] [Related]
5. Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes.
Patra KP; Li F; Carter D; Gregory JA; Baga S; Reed SG; Mayfield SP; Vinetz JM
Infect Immun; 2015 May; 83(5):1799-808. PubMed ID: 25690099
[TBL] [Abstract][Full Text] [Related]
6. A Viral-Vectored Multi-Stage Malaria Vaccine Regimen With Protective and Transmission-Blocking Efficacies.
Yusuf Y; Yoshii T; Iyori M; Mizukami H; Fukumoto S; Yamamoto DS; Emran TB; Amelia F; Islam A; Syafira I; Yoshida S
Front Immunol; 2019; 10():2412. PubMed ID: 31681301
[TBL] [Abstract][Full Text] [Related]
7. Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of
Kurtovic L; Wetzel D; Reiling L; Drew DR; Palmer C; Kouskousis B; Hanssen E; Wines BD; Hogarth PM; Suckow M; Jenzelewski V; Piontek M; Chan JA; Beeson JG
Front Immunol; 2021; 12():641421. PubMed ID: 33815393
[TBL] [Abstract][Full Text] [Related]
8. Comparative analyses of functional antibody-mediated inhibition with anti-circumsporozoite monoclonal antibodies against transgenic Plasmodium berghei.
Nicholas J; Kolli SK; Subramani PA; De SL; Ogbondah MM; Barnes SJ; Ntumngia FB; Adams JH
Malar J; 2023 Nov; 22(1):335. PubMed ID: 37936181
[TBL] [Abstract][Full Text] [Related]
9. Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate.
Plassmeyer ML; Reiter K; Shimp RL; Kotova S; Smith PD; Hurt DE; House B; Zou X; Zhang Y; Hickman M; Uchime O; Herrera R; Nguyen V; Glen J; Lebowitz J; Jin AJ; Miller LH; MacDonald NJ; Wu Y; Narum DL
J Biol Chem; 2009 Sep; 284(39):26951-63. PubMed ID: 19633296
[TBL] [Abstract][Full Text] [Related]
10. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine.
Senkpeil L; Bhardwaj J; Little MR; Holla P; Upadhye A; Fusco EM; Swanson PA; Wiegand RE; Macklin MD; Bi K; Flynn BJ; Yamamoto A; Gaskin EL; Sather DN; Oblak AL; Simpson E; Gao H; Haining WN; Yates KB; Liu X; Murshedkar T; Richie TL; Sim BKL; Otieno K; Kariuki S; Xuei X; Liu Y; Polidoro RB; Hoffman SL; Oneko M; Steinhardt LC; Schmidt NW; Seder RA; Tran TM
JCI Insight; 2024 Apr; 9(11):. PubMed ID: 38687615
[TBL] [Abstract][Full Text] [Related]
11. Adeno-Associated Virus as an Effective Malaria Booster Vaccine Following Adenovirus Priming.
Yusuf Y; Yoshii T; Iyori M; Yoshida K; Mizukami H; Fukumoto S; Yamamoto DS; Alam A; Emran TB; Amelia F; Islam A; Otsuka H; Takashima E; Tsuboi T; Yoshida S
Front Immunol; 2019; 10():730. PubMed ID: 31024558
[TBL] [Abstract][Full Text] [Related]
12. Structural ordering of the
Kucharska I; Thai E; Srivastava A; Rubinstein JL; Pomès R; Julien JP
Elife; 2020 Nov; 9():. PubMed ID: 33253113
[TBL] [Abstract][Full Text] [Related]
13. Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity.
Kurtovic L; Drew DR; Dent AE; Kazura JW; Beeson JG
Front Immunol; 2021; 12():775659. PubMed ID: 34925347
[TBL] [Abstract][Full Text] [Related]
14. Antibody interference by a non-neutralizing antibody abrogates humoral protection against Plasmodium yoelii liver stage.
Vijayan K; Visweswaran GRR; Chandrasekaran R; Trakhimets O; Brown SL; Watson A; Zuck M; Dambrauskas N; Raappana A; Carbonetti S; Kelnhofer-Millevolte L; Glennon EKK; Postiglione R; Sather DN; Kaushansky A
Cell Rep; 2021 Aug; 36(5):109489. PubMed ID: 34348141
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of transmission-blocking potential of Pv22 using clinical Plasmodium vivax infections and transgenic Plasmodium berghei.
Bai J; Liu F; Yang F; Zhao Y; Jia X; Thongpoon S; Roobsoog W; Sattabongkot J; Zheng L; Cui Z; Zheng W; Cui L; Cao Y
Vaccine; 2023 Jan; 41(2):555-563. PubMed ID: 36503858
[TBL] [Abstract][Full Text] [Related]
16. Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1.
Kim MJ; Chu KB; Yoon KW; Kang HJ; Lee DH; Moon EK; Quan FS
Parasites Hosts Dis; 2024 May; 62(2):193-204. PubMed ID: 38835260
[TBL] [Abstract][Full Text] [Related]
17. A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria.
Coutant F; Sanchez David RY; Félix T; Boulay A; Caleechurn L; Souque P; Thouvenot C; Bourgouin C; Beignon AS; Charneau P
PLoS One; 2012; 7(11):e48644. PubMed ID: 23133649
[TBL] [Abstract][Full Text] [Related]
18. Production and Purification of Plasmodium Circumsporozoite Protein in Lactococcus lactis.
Naghizadeh M; Singh SK; Plieskatt J; Ofori EA; Theisen M
Methods Mol Biol; 2024; 2762():109-121. PubMed ID: 38315362
[TBL] [Abstract][Full Text] [Related]
19. Expression of full-length Plasmodium falciparum P48/45 in P. berghei blood stages: A method to express and evaluate vaccine antigens.
Othman AS; Lin JW; Franke-Fayard BM; Kroeze H; van Pul FJA; Chevalley-Maurel S; Ramesar J; Marin-Mogollon C; Jore MM; Morin MJ; Long CA; Sauerwein R; Birkett A; Miura K; Janse CJ; Khan SM
Mol Biochem Parasitol; 2018 Sep; 224():44-49. PubMed ID: 30053393
[TBL] [Abstract][Full Text] [Related]
20. γδ T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations.
Zaidi I; Diallo H; Conteh S; Robbins Y; Kolasny J; Orr-Gonzalez S; Carter D; Butler B; Lambert L; Brickley E; Morrison R; Sissoko M; Healy SA; Sim BKL; Doumbo OK; Hoffman SL; Duffy PE
J Immunol; 2017 Dec; 199(11):3781-3788. PubMed ID: 29079696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
